Moderna Shares Spike on H5N1 News—What's Next for Investors?

Shares of Moderna Inc. NASDAQ: MRNA surged over 12% after news of the first confirmed death from the H5N1 bird flu in the United States. At one point, the stock had climbed over 14% before returning late in the trading session. However, the stock retreated after hours, trading at $47.53, and has since declined further. Moderna TodayMRNAModerna$44.56 -2.97 (-6.25%) 52-Week Range$35.80▼$170.47Price Target$78.83Add to WatchlistGet Moderna alerts:Which isn’t to say there’s no correlation. The company did recei ...